## |TRUSTEES|I Campbell|| |---|---|---| ||I Mallinson|| ||H Fryers|| ||D 5 Tompkins|| ||CThackray|| ||E Podesta|| ||Dr
I H Cameron|| ||Professor 8 M Doyle (appointed|2/5/21)| |PRINCIPAL ADDRESS|Thackray Medical Mueseum|| ||Beckett Street|| ||l.eeds|| ||L59 7LN|| |REGISTERED CHARITY NUMBER|1181361|| |AUDITORS|Thomas Coombs Limited|| ||Statutory
Auditor|| ||Chartered
Accountants|| ||3365The Pentagon|| ||Century Way|| ||Thorpe Park|| ||Leeds|| ||West Yorkshire|| ||LS15828|| |BANKERS|HSBC Bank Pic|| ||33Park Row|| ||Leeds|| ||West Yorkshire|| ||LS11LD|| |SOLICITORS|Wrigleys Solicitors LLP|| ||19Cookridge Street|| ||Leeds|| ||LS2 3AG|| |INVESTMENT MANAGERS|Abrdn|| ||29 East Parade|| ||Leeds|| ||LS15PS|| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |37.5%|FTSEAg Share|FTSEAg Share|||||37.5%|FTSEWorld ex UK|Sterling|| |---|---|---|---|---|---|---|---|---|---|---| |10%|FTSE UK Gilts|All|Stocks||||5%|Sterling Overnight|interbank|Average Rate| |10%|Bank ofAmerica||Merrill|Lynch|Sterling Non-Gilts|||||| |The actual|performance|ofthe investment|||portfolio compared|with|the benchmark|has been:||| ||||||2021/2022|||2020/2021||| |Investment|growth|||||||||| |Benchmark|—ABC||||+6.3%|||N/A||| |Benchmark|—Income constrained||||+8.9%|||+24.2%||| |Actual|||||+8.6%|||+21.0%||| |||||Bank balance and|Income (after|| |---|---|---|---|---|---|---| ||||InvestmentPortfolio|Other Assets|management
costs)|Grants Awarded| |5th|April|2022|68,690,401|E76,308|6178,077|E89,875| |5th|Apnl|2021|68,183,272|E11,752|E159,070|E425,750| |5th|April|2020|E7,010,915|692,441|E215,995|E235,000| |5th|April|2019|68,386,747|617,461|E219,660|E352,790| |5th|April|2018|67,968,271|634,532|E236,557|6794,550| |5th|April|2017|67,952,070|664,223|E209,916|E361,299| |5th|April|2016|f6,928,672|613,964|6225,888|f253,000| |5th|April|2015|E7,449,783|65,566|E202,436|E180,000| |5th|April|2014|E6,941,780|68,331|6221,821|E201,800| |5th|April|2013|66,647,334|68,047|F200,647|E161,500| |5th|April|2012|E5,947,384|E5,213|E188,698|E200,162| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||2022|2021| |---|---|---|---|---|---|---| ||||||Unrestricted|Total| ||||||fund|funds| |||||Notes|E|E| |INCOME AND ENDOWMENTS||FROM||||| |Investment
income|||||239,640|213,506| |EXPENDITURE ON||||||| |Raising funds|||||61,563|54,436| |Charitable
activities||||||| |Governance
costs|||||7,445|5,919| |The Thackray Medical Museum||Company|Limited||79,200|423,750| |Legs 4Africa|||||2,000|2,000| |Action Medical Research|||||5,175|| |Haemochromatosis|UK||||3,500|| |Total|||||158,883|486,105| |Net gains/(losses)
on investments|||||531,590|1,530,743| |NET INCOME/(EXPENDITURE)|||||612,347|1,258,144| |RECONCILIATION
OF FUNDS||||||| |Total funds brought|forward||||8,083,464|6,825,320| |TOTAL FUNDS CARRIED FORWARD|||||8,695,811|8,083,464| ## ## ||||2022|2021| |---|---|---|---|---| ||||Unrestricted|Total| ||||fund|funds| |||Notes|6|6| |FIXED ASSETS||||| |Investments|||8,690,401|8,1B3,272| |CURRENT ASSETS||||| |Debtors||10|1,187|378| |Cash at bank|||75,121|11,374| ||||76,308|11,752| |CREDITORS||||| |Amounts
falling due within one year|||(70,898)|(211,560)| |NET CURRENT ASSETS|||5,410|(99,808)| |TOTAL ASSETS LESS CURRENT LIABILITIES|||8,695,811|B,OB3,464| |NET ASSETS|||S,695,811|8,083,464| |FUNDS||12||| |Unrestdcted|funds||8,695,811|8,083,464| |TOTAL FUNDS|||8,695,811|8,083,464| ## ## ## ## ## ## ## ## ## ## ||INVESTMENT INCOME|INVESTMENT INCOME|||| |---|---|---|---|---|---| |||||2022|2021| |||||E|E| ||Dividends|and similar income received from listed investments||239,640|213,506| |3.|RAISING FUNDS||||| ||Investment|management|costs||| |||||2022|2021.| |||||E|E| ||Portfolio management|||61,563|54,436| ## ## ## |CHARITABLE ACTIVIT|IES|C|OSTS||||||||||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||||||Grant|||||| |||||||||||funding|of||||| |||||||||||activities||Support|||| |||||||||||(see note||costs (see|||| |||||||||||5)f||note 6)
f|Totals
f||| |Governance
costs||||||||||||7,445|7,445||| |The Thackray Medical|Museum|||Company|||||||||||| |Limited||||||||||79,200|||79,200||| |Legs 4Africa||||||||||2,000|||2,000||| |Action Medical Research||||||||||5,175|||5,175||| |Haemochromatosis
UK||||||||||3,500|||3,500||| |||||||||||89,875||7,445|97,320||| |GRANTS PAYABLE|||||||||||||||| |||||||||||||2022
f|2021f||| |The Thackray Medical|Mueseum|||Company||Limited||||||79,200|423,|750|| |Legs 4Africa||||||||||||2,000|2,000||| |Action Medica
I Research||||||||||||5,175|||| |Haemochromatosis
UK||||||||||||3,500|||| |||||||||||||89,875|425,|750|| |Ihe charity
undertakes||its|chantable||activities||through|grant|making|and awarded|grants|to the following|institutions||i| |furtherance
of its charitable|||activities.||||||||||||| |||||||||Grants||Awarded||Paid in the|Grants||| |||||||||unpaid||in the year||year|unpaid||| |||||||Awarded|||at|ended||ended|at||| |||||||2021||06/04/21||2022||2022|05/04/2022||| ||||||||E||E|f||f|E||| |The Thackray Medical Museum|||||||||||||||| |Company
Ltd (trading|asThe Thackray||||||||||||||| |Medical Museum)
Support|||grant||||||||||||| |-9months to 31st December 2021||||||123,750|||82,500|||(82,500)|||| |- Quarterly
awards|(see note 13)||||||||||||||| |||||||||||82,500||(41,250)|41,250||| |Thackray Medical Museum|||—Capital||||||||||||| |works grants||||||111,890|||||||||| |Thackray Medical Museum|||—Covid||||||||||||| |relief grants||||||188,110|||||||||| |Scoping study for medical practitioners|||||||||||||||| |listing project|||||||||3,300|(3,300)|||||| |Contnbutions
to new|collections||||||||||||||| |management
system|||||||||6,960|||||6,960|| |COLLECTION
FUNDING|||||||||||||||| |Haemochromatosis
UK Charity||||||||||3,500||(3,500)|||| |Legs for Africa|||||||2,000|||2,000||||2,000|| |Action Medical Research||||||||||5,175||(5,175)|||| |Total Grants Awarded||||||425,750|||92,760|89,875||(132,425)|50,210||| ## |||||||Governance| |---|---|---|---|---|---|---| |||||||costs| |||||||f| |Governance costs||||||7,445| |Support|costs, included|in|the above, are asfollows:|||| ||||||2022|2021| ||||||Governance|Total| ||||||costs
f|activities
f| |Trustee|Meeting Expenses||||1,629|943| |Sundries|||||23|286| |Legal fees and investment|||performance|review|793|190| |Auditors|Remuneration||||5,000|4,500| ||||||7,445|5,919| ## ## ## ## |COMPARATIVES
|FOR THE STA|TEMENT OF|FINANCIAL ACTIVI|TIES||| |---|---|---|---|---|---|---| |||||||Unrestncted| |||||||fund| |||||||E| |INCOME AND ENDOWMENTS||FROM||||| |Investment
income||||||213,506| |EXPENDITURE ON||||||| |Raising funds||||||54,436| |Charitable
activities||||||| |Governance
costs||||||5,919| |The Thackray MedicalMueseum||Company|Limited|||| |||||||423,750| |Legs 4Africa||||||2,000| |Total||||||486,105| |Net gains on investments||||||1,530,743| |NET INCOME||||||1,258,144| |RECONCILIATION|OF FUNDS|||||| |Total funds brought forward||||||6,825,320| |TOTAL FUNDS CARRIED FORWARD||||||8,083,464| |FIXEDASSET INVESTMENTS||||||| ||||||Cash and|| |||||Listed|settlements|| |||||investments
f|pending
E|Totals
f| |MARKET VALUE||||||| |At 6th April 2021||||7,822,805|360,467|8,183,272| |Additions||||640,607|254,300|894,907| |Disposals||||(1,038,940}||(1,038,940)| |Revaluations||||651,162||651,162| |At 5th April 2022||||8,075,634|614,767|8,690,401| |NET BOOK VALUE||||||| |At 5th April 2022||||8,075,634|614,767|8,690,401| |At 5th April 2021||||7,822,805|360,467|8, 1.83,272| ## ## |||||Cash and|| |---|---|---|---|---|---| ||||Listed|settlements|| ||||investments|pending|Totals| ||||E|E|E| |Valuation|in|2022|8,075,634|614,767|8,690,401| |10.|DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR|DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR|DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR|DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR|DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR|||| |---|---|---|---|---|---|---|---|---| ||||||||2022
f|2021f| ||Other debtors||||||1,187|378| |11.|CREDITORS:|AMOUNTS||FALLING DUE WITHIN ONE YEAR||||| ||||||||2022|2021| ||||||||E|| ||Accrued expenses||||||20,688|18,800| ||Grants payable||||||50,210|92,760| ||||||||70,898|111,560| |12.|MOVEMENT|IN FUNDS||||||| ||||||||Net|| ||||||||movement|At| |||||||At 6/4/21|in funds|5/4/22| |||||||f|f|f| ||Unrestricted|funds||||||| ||General fund|||||8,083,464|612,347|8,695,811| ||TOTAL FUNDS|||||8,083,464|612,347|8,695,811| ||Net movement||in funds,|included
in the above are as follows:||||| ||||||Incoming|Resources|Gains and|Movement| ||||||resources|expended|losses|in funds| ||||||f|f|f|f| ||Unrestricted|funds||||||| ||General
fund||||239,640|(158,883)|531,590|612,347| ||TOTAL FUNDS||||239,640|(158,883)|531,590|612,347| ||Comparatives||for movement||in funds|||| ||||||||Net|| ||||||||movement|At| |||||||At 6/4/20|in funds|5/4/21| |||||||f|f|f| ||Unrestricted|funds||||||| ||General fund|||||6,825,320|1,258,144|8,083,464| ||TOTAL FUNDS|||||6,825,320|1,258,144|8,083,464| ## |||Incoming|Resources|Gains and|Movement| |---|---|---|---|---|---| |||resources|expended|losses|in funds| |||E|E|E|E| |Unrestricted|funds||||| |General fund||213,506|(486,105)|1,530,743|1,258,144| |TOTAL FUNDS||213,506|(486,105)|1,530,743|1,258,144| ## |||2022|2021| |---|---|---|---| |||E|E| |INCOME AND ENDOWMENTS|||| |Investment
income|||| |Dividends
and similar income received from listed|||| |investments||239,640|213,506| |Total incoming resources||239,640|213,506| |EXPENDITURE|||| |Investment
management|costs||| |Porffoiio management||61,563|54,436| |Charitable
activities|||| |Grants to institutions||89,875|425,750| |Support costs|||| |Governance costs|||| |Trustee Meeting Expenses||1,629|943| |Sundries||23|286| |Legalfees||793|190| |Auditors
Remuneration||5,000|4,500| |||7,445|5,919| |Total resources expended||158,883|486,105| |lilet income (expenditure)|before gains and losses|80,757|(272,599)| |Realised recognised
gains|and losses||| |Unrealised
gains/(losses)|on fix ed asset investments|651,162|1,330,113| |Realised gains/(lasses)
on|fixed asset investments|(119,572)|200,630| |Net income||612,347|1,258,144|